Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy L Weigel

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Pharmacology & Therapeutics|July 18, 2013
Androgen receptors in hormone-dependent and castration-resistant prostate cancerAyesha A Shafi, Aihua E Yen, Nancy L Weigel
Steroids|October 26, 2005
Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDREVeronica A Tovar Sepulveda, Nancy L Weigel, Miriam Falzon
The Journal of Steroid Biochemistry and Molecular Biology|September 16, 2014
Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cellsNicole L Moore, Dean P Edwards, Nancy L Weigel
Molecular Cancer Research : MCR|July 9, 2009
Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signalingVandanajay Bhatia, Ramanjaneya V Mula, Nancy L Weigel, et al.
The Journal of Biological Chemistry|August 28, 2004
The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specificRamesh Narayanan, Veronica A Tovar Sepulveda, Miriam Falzon, et al.
The International Journal of Biochemistry & Cell Biology|July 11, 2014
Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cellsWilliam C Krause, Ayesha A Shafi, Manjula Nakka, et al.
Molecular and Cellular Biology|December 17, 2004
Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivatorRamesh Narayanan, Abayomi A Adigun, Dean P Edwards, et al.
Molecular Endocrinology (Baltimore, Md.)|December 17, 2009
Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400Suzanne E Wardell, Ramesh Narayanan, Nancy L Weigel, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 4, 2005
Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cellsLaMonica V Stewart, Besstina Lyles, Ming-Fong Lin, et al.
The Journal of Biological Chemistry|December 15, 2005
Dual roles for the phosphatase PPM1D in regulating progesterone receptor functionDavid A Proia, Bonnie W Nannenga, Lawrence A Donehower, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Pharmacology & Therapeutics|July 18, 2013
Androgen receptors in hormone-dependent and castration-resistant prostate cancerAyesha A Shafi, Aihua E Yen, Nancy L Weigel
Steroids|October 26, 2005
Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDREVeronica A Tovar Sepulveda, Nancy L Weigel, Miriam Falzon
The Journal of Steroid Biochemistry and Molecular Biology|September 16, 2014
Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cellsNicole L Moore, Dean P Edwards, Nancy L Weigel
Molecular Cancer Research : MCR|July 9, 2009
Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signalingVandanajay Bhatia, Ramanjaneya V Mula, Nancy L Weigel, et al.
The Journal of Biological Chemistry|August 28, 2004
The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specificRamesh Narayanan, Veronica A Tovar Sepulveda, Miriam Falzon, et al.
The International Journal of Biochemistry & Cell Biology|July 11, 2014
Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cellsWilliam C Krause, Ayesha A Shafi, Manjula Nakka, et al.
Molecular and Cellular Biology|December 17, 2004
Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivatorRamesh Narayanan, Abayomi A Adigun, Dean P Edwards, et al.
Molecular Endocrinology (Baltimore, Md.)|December 17, 2009
Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400Suzanne E Wardell, Ramesh Narayanan, Nancy L Weigel, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 4, 2005
Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cellsLaMonica V Stewart, Besstina Lyles, Ming-Fong Lin, et al.
The Journal of Biological Chemistry|December 15, 2005
Dual roles for the phosphatase PPM1D in regulating progesterone receptor functionDavid A Proia, Bonnie W Nannenga, Lawrence A Donehower, et al.
Pageof 8